The size of the Neurological Monitoring Devices Market in North America was worth USD 3.25 billion in 2021. It is further estimated to be growing at a CAGR of 6.63% and worth USD 4.48 billion by 2026. North America holds the largest market share in the global neurological monitoring devices market.
Due to the advent of wearable medical devices, the greatest shifting trend is observed in the commercialization and commoditization of EEG devices. Manufacturers are introducing disruptive devices that can be used and interpreted easily by a user, which is a growing awareness of neurological disorders at an unprecedented level.
The North American region offers an enormous untapped market for it because of increasing awareness of neurological disorders, a rise in purchasing power, and an increasing number of people with multiple sclerosis, epilepsy, cerebrovascular diseases, Parkinson’s, and Alzheimer’s diseases. Increases in the prevalence of post-surgical cerebrovascular accidents have triggered the need for more improved and automated devices. The high cost of devices is majorly restraining market growth.
This report has been segmented and sub-segmented the North American Neurological Monitoring Devices Market into the following categories:
By Type:
By Procedure:
By Therapeutic Application:
By End-Users:
By Country:
Regionally, the USA is leading the market with the highest number of shares, followed by Canada.
Key market players include CAS Medical Systems Inc., Compumedics Ltd., Natus Medical Inc., Philips Healthcare, GE Healthcare, AMD Global Telemedicine, Intel Corporation, Johnson & Johnson, InTouch Health, InTechnology, MEG International Services Ltd., Rimed Inc., Siemens Healthcare, Medtronic Inc., Electrical Geodesics Incorporated, Nihon Kohden Corporation, and Advanced Brain Monitoring.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 Monitors of Intracranial Pressure & Blood Flow Dynamics
5.1.2.1 Intracranial Pressure Monitor
5.1.2.2 Jugular Venous Oximetry
5.1.2.3 Transcranial Doppler (TCD) Ultrasonography
5.1.2.4 Near-Infrared Spectroscopy
5.1.2.5 Brain Tissue Oxygen Tension Monitor
5.1.3 Monitors of Brain Electrical Activity
5.1.3.1 Electroencephalography
5.1.3.2 Evoked Potentials
5.1.4 Y-o-Y Growth Analysis, By Type
5.1.5 Market Attractiveness Analysis, By Type
5.1.6 Market Share Analysis, By Type
5.2 Procedure
5.2.1 Introduction
5.2.2 Non-Invasive
5.2.3 Invasive
5.2.4 Y-o-Y Growth Analysis, By Procedure
5.2.5 Market Attractiveness Analysis, By Procedure
5.2.6 Market Share Analysis, By Procedure
5.3 Therapeutic Application
5.3.1 Introduction
5.3.2 Traumatic Brain Injuries
5.3.3 Stroke
5.3.4 Dementia
5.3.5 Headache Disorders
5.3.6 Sleep Disorders
5.3.7 Epilepsy
5.3.8 Parkinson’s Disease
5.3.9 Huntington’s Disease
5.3.10 Y-o-Y Growth Analysis, By Therapeutic Application
5.3.11 Market Attractiveness Analysis, By Therapeutic Application
5.3.12 Market Share Analysis, By Therapeutic Application
5.4 End User
5.4.1 Introduction
5.4.2 Hospitals
5.4.3 Neurological Centers and Institutions
5.4.4 Clinics & Ambulatory Surgical Centers
5.4.5 Diagnostic Centers
5.4.6 Ambulances
5.4.7 Y-o-Y Growth Analysis, By End User
5.4.8 Market Attractiveness Analysis, By End User
5.4.9 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.3.3 By Procedure
6.1.3.4 By Therapeutic Application
6.1.3.5 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.4.3 By Procedure
6.1.4.4 By Therapeutic Application
6.1.4.5 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.1.5.3 By Procedure
6.1.5.4 By Therapeutic Application
6.1.5.5 By End User
6.2 U.S
6.3 Canada
6.4 Rest of North America
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 CAS Medical Systems Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Compumedics Ltd.
8.3 Natus Medical Inc.
8.4 Philips Healthcare
8.5 GE Healthcare
8.6 AMD Global Telemedicine
8.8 Intel Corporation
8.9 Johnson & Johnson
8.10 InTouch Health
8.11 InTechnology
8.12 MEG International Services Ltd.
8.13 Advanced Brain Monitoring
8.14 Rimed Inc.
8.15 Siemens Healthcare
8.16 Medtronic Inc.
8.17 Electrical Geodesics Incorporated
8.18 Nihon Kohden Corporation
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
